Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Zanidatamab Combined With Chemotherapy as Neoadjuvant Therapy for HER2-high Expression G/GEJC [Phase 2]
A Phase 2 neoadjuvant trial is evaluating Zanidatamab in combination with chemotherapy for HER2-high gastric/gastroesophageal junction adeno…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy [Phase 3]
The PREACT Phase 3 trial comparing chemoradiotherapy versus chemotherapy followed by D2 gastrectomy and adjuvant chemotherapy for locally ad…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial update on bemarituzumab in combination with other anti-cancer therapies for previously untreated advanced gas…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
This clinical trial update reports that City of Hope Medical Center's remote telemonitoring study of patient-generated physiological data an…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Minimal Residual Disease in Solid Malignancies [NA]
This clinical trial update describes a study evaluating minimal residual disease in solid malignancies across several cancers, and it is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer [NA]
This clinical trial update evaluates the effectiveness of an educational program intended to enhance emotional competencies in patients unde…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer [NA]
Feasibility study evaluating auricular acupressure for appetite and weight in patients with stage II–IV gastric, esophageal, or pancreatic c…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
A completed clinical trial evaluating nivolumab in patients with unresectable, advanced or metastatic gastric cancer and gastroesophageal ju…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)
A ClinicalTrials.gov entry for the AROMA2 study examines whether volatile biomarker profiles can augment assessment of esophagogastric cance…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer. [NA]
This clinical trial assesses the efficacy and safety of laparoscopic proximal gastrectomy with LPG-tbROSF versus laparoscopic total gastrect…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers [Phase 2]
Phase 2 clinical trial focusing on methods to characterize resistance to antibody-drug conjugates in solid tumors and to identify clinically…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers [Phase 1]
Phase 1 trial of KK-LC-1 targeted T cell receptor gene therapy across KK-LC-1 positive gastric, breast, cervical, and lung cancers; the stud…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]
This is a Phase 2 randomized study evaluating serplulimab in combination with chemotherapy for locally advanced gastric cancer (gastric aden…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: REVOLUTION Surgery (REVOLUTION Surgery)
The REVOLUTION Surgery trial, led by the University of Edinburgh, is currently recruiting and studying cachexia alongside multiple cancers i…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update reporting ongoing recruitment for a combination therapy (agenT-797 with Botensilimab, Balstilimab, Ramucirumab…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy [NA]
Clinical trial evaluating neurotoxicity in patients with metastatic gastric cancer who receive Phycocare or placebo during oxaliplatin-based…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment [Phase 4]
A Phase 4 trial is evaluating Saccharomyces boulardii in combination with bismuth quadruple therapy as a rescue treatment for Helicobacter p…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS) [Phase 2]
This Phase 2 study (MRD-ATLAS) is evaluating whether circulating tumor DNA–based minimal residual disease guidance can inform adjuvant thera…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA) [Phase 3]
A Phase 3 trial (FRUTIGA) evaluating Fruquintinib plus Paclitaxel in second-line advanced gastric cancer completed.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab combined with XELOX as neoadjuvant therapy for locally advanced gastric or gastroesophageal junction a…
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]
A Phase 1 study of BLU-222 in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Distribution Characteristics of Helicobacter Pylori
Clinical trial update from Jilin University about the distribution characteristics of Helicobacter pylori in patients with Helicobacter pylo…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
This clinical trial update describes a noninvasive miRNA-based test being explored for screening gastrointestinal cancers. It is currently r…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT
A clinical trial evaluating AI-assisted detection and staging of gastric cancer using contrast-enhanced CT is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Utidelone capsules in combination with fluoropyrimidine- and platinum-containing therapy as first-line…